Press Release
-
EG BioMed Unveils Revolutionary Cancer Detection Tests
EG BioMed is proud to announce two groundbreaking advancements in cancer detection: the EG-Breast blood test and the EG-Pancreatic blood test. These innovative tests are designed to identify breast and pancreatic cancers at an early stage without the need for radiation or invasive procedures. Each test requires only a single 10 mL blood sample, which…
-
EG-Breast Blood Test-P1: Revolutionizing Breast Cancer Monitoring with cfDNA Methylation Detection
Dr. Chih-Ming Su is the Director of Breast Health Care Center, Shuang Ho Hospital, Taipei Medical University, Taiwan. Dr. Chih-Ming Su’s feedback highlights the critical need for more sensitive and reliable blood-based monitoring tools in the management of breast cancer. The EG-Breast Blood Test-P1, with its innovative approach to detecting aberrant methylation in cfDNA, has…
-
Urgent Need for 3-Year Pancreatic Cancer Blood Tests in New-Onset Diabetes Patients
According to a report by the National Cancer Institute in July 2021, 1 in 100 newly diagnosed diabetic patients is diagnosed with pancreatic cancer within three years. This finding has been supported by large-scale sample studies published in several medical journals, highlighting the necessity for close monitoring of pancreatic cancer in diabetic patients after diagnosis.…